NUS vs PG
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
NUS presents a classic 'value trap' profile, characterized by a weak Piotroski F-Score of 3/9 and a bearish technical trend of 0/100. While the company is trading at a massive discount to its Graham Number ($34.57) and Intrinsic Value ($22.26), this is offset by a severe revenue contraction of -16.90% YoY. The balance sheet remains healthy with low debt (D/E 0.38) and strong liquidity, but the operational decay suggests the market is pricing in a permanent decline in the business model.
PG exhibits a stable financial foundation with a Piotroski F-Score of 6/9, but it is severely overvalued relative to its deterministic baselines. The current price of $145.71 represents a massive premium over the Graham Number ($58.45) and Intrinsic Value ($47.25), while a PEG ratio of 3.92 indicates the valuation is disconnected from its stagnant growth. Negative earnings growth (-5.40% YoY) combined with bearish insider activity and a 0/100 technical trend suggests significant downside risk despite the company's operational efficiency.
Compare Another Pair
Related Comparisons
NUS vs PG: Head-to-Head Comparison
This page compares Nu Skin Enterprises, Inc. (NUS) and The Procter & Gamble Company (PG) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.